• 1. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 2. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 3. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 4. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
• 5. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642

Recent Advances in the Study of 4-Ethylpyridin-3-amine (CAS: 101084-17-7) and Its Applications in Chemical Biology and Medicine

4-Ethylpyridin-3-amine (CAS: 101084-17-7) is a pyridine derivative that has garnered significant attention in recent years due to its potential applications in chemical biology and medicinal chemistry. This compound, characterized by its ethyl substitution at the 4-position of the pyridine ring and an amino group at the 3-position, serves as a versatile building block for the synthesis of more complex molecules. Recent studies have explored its role in drug discovery, particularly as a scaffold for developing novel therapeutic agents targeting various diseases, including cancer, infectious diseases, and neurological disorders.

One of the key areas of research involving 4-Ethylpyridin-3-amine is its use as an intermediate in the synthesis of kinase inhibitors. Kinases are critical enzymes involved in signal transduction pathways, and their dysregulation is often associated with cancer and other proliferative diseases. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of 4-Ethylpyridin-3-amine exhibit potent inhibitory activity against specific tyrosine kinases, such as EGFR and HER2, which are frequently overexpressed in breast and lung cancers. The study highlighted the compound's ability to form key hydrogen bonds and hydrophobic interactions within the kinase active site, leading to enhanced selectivity and reduced off-target effects.

In addition to its role in kinase inhibition, 4-Ethylpyridin-3-amine has also been investigated for its potential in antimicrobial drug development. A recent preprint on bioRxiv reported that certain analogs of this compound exhibit broad-spectrum activity against drug-resistant bacterial strains, including methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. The researchers attributed this activity to the compound's ability to disrupt bacterial cell membrane integrity and interfere with essential metabolic pathways. These findings suggest that 4-Ethylpyridin-3-amine could serve as a promising lead for the development of new antibiotics to address the growing threat of antimicrobial resistance.

Another notable application of 4-Ethylpyridin-3-amine is in the field of neuropharmacology. A 2022 study in ACS Chemical Neuroscience explored its potential as a modulator of neurotransmitter receptors, particularly those involved in glutamatergic signaling. The researchers synthesized a series of derivatives and evaluated their effects on NMDA and AMPA receptors, which play critical roles in synaptic plasticity and cognitive function. Preliminary results indicated that certain derivatives could selectively modulate receptor activity, offering potential therapeutic benefits for neurodegenerative diseases such as Alzheimer's and Parkinson's.

The synthetic versatility of 4-Ethylpyridin-3-amine has also been leveraged in the development of fluorescent probes for biological imaging. A 2023 publication in Chemical Communications described the design of a novel probe based on this compound, which exhibits strong fluorescence in the near-infrared region. This probe was successfully used to visualize intracellular reactive oxygen species (ROS) in live cells, providing a valuable tool for studying oxidative stress-related pathologies, including inflammation and cancer.

Despite these promising developments, challenges remain in the optimization of 4-Ethylpyridin-3-amine-based compounds for clinical use. Issues such as bioavailability, metabolic stability, and potential toxicity need to be addressed through further structural modifications and preclinical studies. However, the growing body of research underscores the compound's potential as a valuable scaffold in drug discovery and chemical biology. Future studies are expected to explore its applications in other therapeutic areas, such as immunomodulation and antiviral therapy, further expanding its utility in biomedical research.

• 3430-27-1(4-methylpyridin-3-amine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)